Jason Hoitt

Chief Patient Officer

Chief Patient Officer at Stoke Therapeutics, Inc., filing insider transactions between 2026-03-17 and 2026-03-18.

Total Purchases

—

0 transactions

Total Sales

$119K

5 transactions

Companies Traded

5 total filings

Active Since

2026-03-17

Last: 2026-03-18

Companies

Stoke Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-18	STOK	Sale	139	$31.79	$4K	10.3K	SEC ↗
2026-03-18	STOK	Sale	1,762	$31.28	$55K	10.4K	SEC ↗
2026-03-18	STOK	Sale	30	$32.85	$986	10.3K